Interim report January – June 2005

- Sales in the second quarter 2005 amounted to 93.5 MSEK (88.9) and sales in the period January – June 2005 to 165.4 MSEK (175.9). - The operating result for the second quarter amounted to –15.5 MSEK (-13.4) and the operating result for the period January – June to -37.7 MSEK (-36.1). - The net result for the second quarter was positive, amounting to 0.8 MSEK (-11.3). - Earnings per share for the second quarter amounted to 0.01 SEK (-0.19) and earnings per share for the period January - June to –0.20 SEK (-0.56). - The business of the American company Argonaut Technologies Inc was acquired and is included in Biotage from June 3, 2005. The purchase price, excluding acquisition costs, was approx. 21.1 MUSD, 157 MSEK, and Biotage has obtained short-term bank financing to the amount of 140 MSEK. Through the acquisition Biotage gets additional annual sales of approx. 125 MSEK. - In late June Biotage decided to make two new share issues, with a total of 6.4 million shares. Through these issues the company will gain new capital amounting to approx. 62 MSEK after deduction of costs. Contact: Jeff Bork, President and CEO Tel: +46 734-22 16 60 Mats-Olof Wallin, CFO Tel: +46 705-93 52 73